Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated... Purpose Annexin A5 (ANXA5) is a protein abundantly expressed in normal placenta where it contributes to the healthy outcome of a pregnancy. Lower ANXA5 levels have been observed in M2/ANXA5 haplotype carrying chorion. Consequently, this study aimed to assess the potential association of M2 maternal carrier status with the risk of recurrent pregnancy loss (RPL), the timing of miscarriages, and other obstetric complications, for the first time in a population from Latin America. Methods This study was designed as a prospective recruitment of RPL patients with post hoc analysis. The distribution of the M2/ANXA5 haplotype was compared between a group of 229 Argentine women with RPL and 100 parous controls, and was further analyzed in subgroups of patients stratified according to the timing of miscarriages and in relation to other obstetric complications. Results No significant differences were found in the distribution of M2 haplotype among either RPL patients or the subgroups with embryonic, early fetal, or late fetal losses compared to parous controls. Notwithstanding, maternal M2/ANXA5 was found to be independently associated with a higher risk of suffering intrauterine growth restriction (IUGR) and/or preeclampsia (PE). Simultaneously, the presence of inherited and/or acquired thrombophilia also proved to be an independent http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Assisted Reproduction and Genetics Springer Journals

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

Download PDF
8 pages

Loading next page...
 
/lp/springer_journal/maternal-carriers-of-the-anxa5-m2-haplotype-are-exposed-to-a-greater-Ct0wVHicdF
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Gynecology; Reproductive Medicine; Human Genetics
ISSN
1058-0468
eISSN
1573-7330
DOI
10.1007/s10815-018-1142-4
pmid
29497952
Publisher site
See Article on Publisher Site

Abstract

Purpose Annexin A5 (ANXA5) is a protein abundantly expressed in normal placenta where it contributes to the healthy outcome of a pregnancy. Lower ANXA5 levels have been observed in M2/ANXA5 haplotype carrying chorion. Consequently, this study aimed to assess the potential association of M2 maternal carrier status with the risk of recurrent pregnancy loss (RPL), the timing of miscarriages, and other obstetric complications, for the first time in a population from Latin America. Methods This study was designed as a prospective recruitment of RPL patients with post hoc analysis. The distribution of the M2/ANXA5 haplotype was compared between a group of 229 Argentine women with RPL and 100 parous controls, and was further analyzed in subgroups of patients stratified according to the timing of miscarriages and in relation to other obstetric complications. Results No significant differences were found in the distribution of M2 haplotype among either RPL patients or the subgroups with embryonic, early fetal, or late fetal losses compared to parous controls. Notwithstanding, maternal M2/ANXA5 was found to be independently associated with a higher risk of suffering intrauterine growth restriction (IUGR) and/or preeclampsia (PE). Simultaneously, the presence of inherited and/or acquired thrombophilia also proved to be an independent

Journal

Journal of Assisted Reproduction and Genetics – Springer Journals

Published: Mar 1, 2018

References

  • Recurrent pregnancy loss: etiology, diagnosis, and therapy
    Ford, HB; Schust, DJ
  • Thrombophilic disorders and fetal loss: a meta-analysis
    Rey, E; Kahn, SR; David, M; Shrier, I
  • Pregnancy failure and heritable thrombophilia
    Middeldorp, S
  • The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies
    Rodger, MA; Betancourt, MT; Clark, P; Lindqvist, PG; Dizon-Townson, D; Said, J
  • Inherited thrombophilia and gestational vascular complications
    Grandone, E; Margaglione, M
  • The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation
    Krikun, G; Lockwood, CJ; Wu, XX; Zhou, XD; Guller, S; Calandri, C
  • Clustering of lipid-bound annexin V may explain its anticoagulant effect
    Andree, HA; Stuart, MC; Hermens, WT; Reutelingsperger, CP; Hemker, HC; Frederik, PM
  • Antibody-mediated interference with annexins in the antiphospholipid syndrome
    Rand, JH; Wu, XX
  • Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and foetal loss
    Ueki, H; Mizushina, T; Laoharatchatathanin, T; Terashima, R; Nishimura, Y; Rieanrakwong, D
  • Review: Annexin-A5 and cell membrane repair
    Bouter, A; Carmeille, R; Gounou, C; Bouvet, F; Degrelle, SA; Evain-Brion, D
  • Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion
    Rand, JH; Wu, XX; Guller, S; Gil, J; Guha, A; Scher, J
  • Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures
    Matsubayashi, H; Arai, T; Izumi, S; Sugi, T; McIntyre, JA; Makino, T
  • Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia
    Gourvas, V; Soulitzis, N; Konstantinidou, A; Dalpa, E; Koukoura, O; Koutroulakis, D
  • A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss
    Bogdanova, N; Horst, J; Chlystun, M; Croucher, PJ; Nebel, A; Bohring, A
  • Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2
    Chinni, E; Tiscia, GL; Colaizzo, D; Vergura, P; Margaglione, M; Grandone, E
  • Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele
    Markoff, A; Gerdes, S; Feldner, S; Bogdanova, N; Gerke, V; Grandone, E
  • Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications
    Tiscia, G; Colaizzo, D; Chinni, E; Pisanelli, D; Scianname, N; Favuzzi, G
  • Polymorphisms in the annexin A5 gene promoter in Japanese women with recurrent pregnancy loss
    Miyamura, H; Nishizawa, H; Ota, S; Suzuki, M; Inagaki, A; Egusa, H
  • Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study
    Rogenhofer, N; Engels, L; Bogdanova, N; Tuttelmann, F; Markoff, A; Thaler, C
  • Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk
    Tuttelmann, F; Ivanov, P; Dietzel, C; Sofroniou, A; Tsvyatkovska, TM; Komsa-Penkova, RS
  • Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion
    Demetriou, C; Abu-Amero, S; White, S; Peskett, E; Markoff, A; Stanier, P
  • M2/ANXA5 haplotype as a predisposition factor in Malay women and couples experiencing recurrent spontaneous abortion: a pilot study
    Thean Hock, T; Bogdanova, N; Kai Cheen, A; Kathirgamanathan, S; Bin Abdullah, R; Mohd Yusoff, N
  • The M2 haplotype in the ANXA5 gene is an independent risk factor for idiopathic small-for-gestational age newborns
    Tiscia, G; Colaizzo, D; Favuzzi, G; Vergura, P; Martinelli, P; Margaglione, M
  • Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia
    Ota, S; Miyamura, H; Nishizawa, H; Inagaki, H; Inagaki, A; Inuzuka, H
  • Definitions of infertility and recurrent pregnancy loss: a committee opinion
  • Diagnostic methods of ectopic pregnancy and early pregnancy loss: a review of the literature
    Hamza, A; Meyberg-Solomayer, G; Juhasz-Boss, I; Joukhadar, R; Takacs, Z; Solomayer, EF
  • Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group
    Kolte, AM; Bernardi, LA; Christiansen, OB; Quenby, S; Farquharson, RG; Goddijn, M
  • Idiopathic recurrent pregnancy loss recurs at similar gestational ages
    Heuser, C; Dalton, J; Macpherson, C; Branch, DW; Porter, TF; Silver, RM
  • Pre-eclampsia: pathophysiology, diagnosis, and management
    Uzan, J; Carbonnel, M; Piconne, O; Asmar, R; Ayoubi, JM
  • Placental abruption: epidemiology, risk factors and consequences
    Tikkanen, M
  • Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study
    Unterscheider, J; Daly, S; Geary, MP; Kennelly, MM; McAuliffe, FM; O'Donoghue, K
  • Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum
    Stagnaro-Green, A; Abalovich, M; Alexander, E; Azizi, F; Mestman, J; Negro, R
  • Haemostatic reference intervals in pregnancy
    Szecsi, PB; Jorgensen, M; Klajnbard, A; Andersen, MR; Colov, NP; Stender, S
  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    Miyakis, S; Lockshin, MD; Atsumi, T; Branch, DW; Brey, RL; Cervera, R
  • Inferring continental ancestry of argentineans from autosomal, Y-chromosomal and mitochondrial DNA
    Corach, D; Lao, O; Bobillo, C; Gaag, K; Zuniga, S; Vermeulen, M
  • The impact of modern migrations on present-day multi-ethnic Argentina as recorded on the mitochondrial DNA genome
    Catelli, ML; Alvarez-Iglesias, V; Gomez-Carballa, A; Mosquera-Miguel, A; Romanini, C; Borosky, A
  • Heterogeneity in genetic admixture across different regions of Argentina
    Avena, S; Via, M; Ziv, E; Perez-Stable, EJ; Gignoux, CR; Dejean, C
  • The placenta in pre-eclampsia and intrauterine growth restriction
    Roberts, DJ; Post, MD
  • New insights into mechanisms behind miscarriage
    Larsen, EC; Christiansen, OB; Kolte, AM; Macklon, N
  • Genomic insights into the ancestry and demographic history of South America
    Homburger, JR; Moreno-Estrada, A; Gignoux, CR; Nelson, D; Sanchez, E; Ortiz-Tello, P
  • Antiphospholipid antibodies in women at risk for preeclampsia
    Branch, DW; Porter, TF; Rittenhouse, L; Caritis, S; Sibai, B; Hogg, B
  • The factor V Leiden mutation may predispose women to severe preeclampsia
    Dizon-Townson, DS; Nelson, LM; Easton, K; Ward, K
  • Increased frequency of genetic thrombophilia in women with complications of pregnancy
    Kupferminc, MJ; Eldor, A; Steinman, N; Many, A; Bar-Am, A; Jaffa, A
  • Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis
    Dudding, T; Heron, J; Thakkinstian, A; Nurk, E; Golding, J; Pembrey, M
  • Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction
    Sifakis, S; Soufla, G; Koukoura, O; Soulitzis, N; Koutroulakis, D; Maiz, N
  • Mechanisms of implantation: strategies for successful pregnancy
    Cha, J; Sun, X; Dey, SK
  • Placental vascular pathology as a mechanism of disease in pregnancy complications
    Kovo, M; Schreiber, L; Bar, J
  • Placental pathology in pregnancy complications
    Huppertz, B
  • Update: consequences of abnormal fetal growth
    Chernausek, SD
  • Fetal growth and adult diseases
    Ozanne, SE; Fernandez-Twinn, D; Hales, CN